Propranolol and the treatment of rheumatoid arthritis.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780230220PMID 7362673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.

  1980cited by this paper
• Sclerosing peritonitis and propranolol.

  1978cited by this paper
• Drugs affecting the release of rheumatoid factor in a plaque-forming cell assay.

  1978cited by this paper
• Differential effects of propranolol on lymphocyte rosette formation and response to plant mitogens.

  1978cited by this paper
• Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

  1977cited by this paper
• The Effect of Propranolol on Microvascular Injury in Acute Myocardial Ischemia

  1977cited by this paper
• Effects of propranolol and pindolol on platelet aggregation and serotonin release.

  1977cited by this paper
• Propranolol and Peyronie's disease.

  1977cited by this paper
• Letter: Propranolol and platelet aggregation.

  1975cited by this paper
• Complement fixation by rheumatoid factor.

  1975cited by this paper
• Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol

  1974cited by this paper

• Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis

  2021cites this paper
• β2 adrenergic receptor mediates noradrenergic action to induce CREB phosphorylation in satellite glial cells of dorsal root ganglia to regulate visceral hypersensitivity.

  2021cites this paper
• Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer

  2020cites this paper
• PATHOGENESIS OF FIBROMYALGIA IN PATIENTS WITH AUTOIMMUNE DISEASES: SCOPING REVIEW FOR HYPOTHESIS GENERATION

  2020cites this paper
• Noradrenaline induces peripheral antinociception by endogenous opioid release

  2018cites this paper
• Unraveling the Complexities of Idiopathic Pain Disorders: From Mouse to Man

  2016cites this paper
• Persistent Catechol-O-methyltransferase–dependent Pain Is Initiated by Peripheral &bgr;-Adrenergic Receptors

  2016cites this paper
• Results of a Pilot Multicenter Genotype-based Randomized Placebo-controlled Trial of Propranolol to Reduce Pain After Major Thermal Burn Injury

  2015cites this paper
• NSAIDs induce peripheral antinociception by interaction with the adrenergic system.

  2015cites this paper
• Angiotensin-(1-7) through Mas receptor activation induces peripheral antinociception by interaction with adrenoreceptors.

  2015cites this paper
• Structural and functional interactions between six-transmembrane μ-opioid receptors and β2-adrenoreceptors modulate opioid signaling

  2015cites this paper
• Natural Diterpenes from Coffee, Cafestol, and Kahweol Induce Peripheral Antinoceception by Adrenergic System Interaction

  2015cites this paper
• Suppression of adrenal gland‐derived epinephrine enhances the corticosterone‐induced antinociceptive effect in the mouse formalin test

  2014cites this paper
• CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System

  2013cites this paper
• Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β-Adrenoceptors

  2013cites this paper
• Catechol-O-Methyltransferase Genotype Predicts Pain Severity in Hospitalized Burn Patients

  2012cites this paper
• Potential Processes Involved in the Initiation and Maintenance of Whiplash-Associated Disorders: Discussion Paper 3

  2011cites this paper
• Potential role of stress systems in the pathogenesis of whiplash associated disorders

  2011cites this paper
• The Potential Contribution of Stress Systems to the Transition to Chronic Whiplash-Associated Disorders

  2011cites this paper
• Neurobiological mechanisms of pain in sickle cell disease.

  2010cites this paper
• Genetic basis for individual variation in pain perception among endodontic patients

  2009cites this paper
• OF β 2 ADRENERGIC RECEPTOR HAPLOTYPES

  2008cites this paper
• Catechol‐O‐methyltransferase inhibition increases pain sensitivity through activation of both β2‐ and β3‐adrenergic receptors

  2007cites this paper
• Epinephrine-induced excitation and sensitization of rat C-fiber nociceptors.

  2005cites this paper
• The importance of timing of adrenergic drug delivery in relation to the induction and onset of adjuvant-induced arthritis.

  2004cites this paper
• Immunoregulation by innervation

  2003cites this paper
• Immunopathogenesis of Rheumatic Diseases in the Context of Neuroendocrine Interactions

  2002cites this paper
• Effect of repeated desipramine and fluoxetine administration on post-adjuvant arthritis.

  2000cites this paper
• Interactions of autonomic nervous, neuroendocrine, and immune systems in rheumatoid arthritis.

  2000cites this paper
• Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors.

  1999cites this paper
• Autonomic neuropeptides in the interface membrane of aseptic loose hip prostheses.

  1999cites this paper
• Dual role for noradrenergic innervation of lymphoid tissue and arthritic joints in adjuvant-induced arthritis.

  1999cites this paper
• Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system.

  1998cites this paper
• Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors.

  1997cites this paper
• Prospects and advances in hormonal immunomodulatory therapy.

  1996cites this paper
• Application of 6-hydroxydopamine into the fatpads surrounding the draining lymph nodes exacerbates adjuvant-induced arthritis.

  1996cites this paper
• Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: effects of capsaicin treatment.

  1995cites this paper
• Psychoneuroimmunology: conditioning and stress.

  1993cites this paper
• Innervation of lymphoid organs and implications in development, aging, and autoimmunity.

  1992cites this paper
• Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis.

  1992cites this paper
• Arthritis and drug therapy in the hypertension clinic.

  1988cites this paper
• Beta 2-adrenergic mechanisms in experimental arthritis.

  1988cites this paper
• Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

  1986cites this paper
• Adverse Reactions and Interactions with β-Adrenoceptor Blocking Drugs

  1986cites this paper
• Drug-Induced Arthritis and Arthralgia

  1984cites this paper
• Arthropathy induced by beta blockade.

  1983cites this paper
• Polyarthritis following propranolol.

  1981cites this paper
• Immunological assessment of patients with rheumatoid arthritis--evaluation of the effects of propranolol.

  1981cites this paper